Natalia Laufer

Summary

Publications

  1. ncbi No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy
    N Laufer
    Centro Nacional de Referencia para el SIDA, Universidad de Buenos Aires, Argentina
    Antiviral Res 92:497-9. 2011
  2. ncbi HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin
    N Laufer
    Centro Nacional de Referencia para el SIDA, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, Argentina
    Antiviral Res 90:92-7. 2011
  3. ncbi Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin
    Natalia Laufer
    Infectious Diseases Unit, Hospital Clinic, Barcelona, Spain
    Antivir Ther 13:953-7. 2008
  4. ncbi Longitudinal analysis of the 5'UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patients
    Federico Bolcic
    Instituto de Investigaciones Biomédicas en Retrovirus y Sida, Facultad de Medicina, Universidad de Buenos Aires, Argentina
    Antiviral Res 95:72-81. 2012
  5. ncbi A clustering phenomenon among HCV-1a strains among patients coinfected with HIV from Buenos Aires, Argentina
    Federico Bolcic
    Microbiology Department, National Reference Center for AIDS Research, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
    J Med Virol 84:570-81. 2012
  6. ncbi HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors
    Jorge F Quarleri
    Centro Nacional de Referencia para el SIDA, Dto Microbiologia, Facultad de Medicina, Universidad de Buenos Aires, CONICET, Argentina
    Acta Gastroenterol Latinoam 37:76-83. 2007
  7. ncbi Telomerase activity in peripheral blood mononuclear cells from HIV and HIV-HCV coinfected patients
    Rita Reynoso
    Centro Nacional de Referencia para el SIDA, Dto Microbiologia, Facultad de Medicina, Universidad de Buenos Aires, Argentina
    Virus Res 147:284-7. 2010
  8. ncbi Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen
    Hector Perez
    Fernandes Hospital, Infectious Diseases Unit, Buenos Aires, Argentina
    Antivir Ther 13:135-9. 2008
  9. ncbi ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis
    Javier Oscar Jurado
    Department of Biological Chemistry, University of Buenos Aires, School of Sciences, Buenos Aires, Argentina
    J Int AIDS Soc 15:17428. 2012
  10. ncbi Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
    M Eugenia Socías
    Hospital J A Fernandez, Cerviño 3356, Buenos Aires, Argentina
    J Int AIDS Soc 14:40. 2011

Collaborators

  • Pedro Cahn
  • Gabriela Turk
  • Carlos Zala
  • Carolina Torres
  • Carina Cesar
  • Francesc Vidal
  • Josep Mallolas
  • A Martinez
  • Carlos Remondegui
  • Jorge F Quarleri
  • Josephine H Cox
  • Leandro R Jones
  • Federico Bolcic
  • Horacio Salomon
  • Rita Reynoso
  • Lucila Cassino
  • Hector Perez
  • Javier Oscar Jurado
  • Omar Sued
  • M Eugenia Socías
  • Ivana Belén Alvarez
  • Juan Trinchero
  • Eduardo Abbate
  • Virginia Pasquinelli
  • Maria Florencia Quiroga
  • Rosa María Musella
  • Gustavo Javier Martínez
  • Maria E Lázaro
  • Manuel Gomez Carrillo
  • Marcela Ortiz
  • Claudia Galloso
  • J Gonzalo Tomás
  • Gustavo Echenique
  • Juan Castelli
  • Eliana Loiza
  • Ravi Kavasery
  • Lorena Abusamra
  • Javier Yave
  • Daniel Pryluka
  • I Figueroa
  • Mariana Ceriotto
  • Norma Porteiro
  • Inés Zapiola
  • Horacio Mingrone
  • M Belén Bouzas
  • Patricia Patterson
  • Dario Dilernia
  • Valeria Fink
  • Ariel Braverman
  • ANDREA DUARTE
  • María Collins
  • Ana Gun
  • Palmira Garda
  • María I Figueroa
  • Graciela Ben
  • Daniel Cangelosi
  • Carolina Acuipil
  • Viviana Alonso
  • Marcela Acosta
  • Maria B Bouzas
  • Liliana Amante
  • Fabio Crudo
  • Cecilia Cánepa
  • Alejandro Krolewiecki
  • Osvaldo Cando
  • Raúl Román
  • Patricia Maldonado
  • E Lazaro
  • Mercedes Cabrini
  • Alberto Leoni
  • Rodolfo Campos
  • Maria Rolon
  • Jorge Lottner
  • Patricia Coll
  • Alejandro Gomez
  • Moira Vignoles

Detail Information

Publications12

  1. ncbi No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy
    N Laufer
    Centro Nacional de Referencia para el SIDA, Universidad de Buenos Aires, Argentina
    Antiviral Res 92:497-9. 2011
    ..This data suggests that despite the promising results reported for HCV genotype 4 mono-infected patients, NTZ exhibit poor activity as monotherapy in HIV/HCV co-infected patients with genotype 1...
  2. ncbi HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin
    N Laufer
    Centro Nacional de Referencia para el SIDA, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, Argentina
    Antiviral Res 90:92-7. 2011
    ..Viral kinetics has emerged as one of the best prognostic factors of treatment outcome...
  3. ncbi Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin
    Natalia Laufer
    Infectious Diseases Unit, Hospital Clinic, Barcelona, Spain
    Antivir Ther 13:953-7. 2008
    ..The aim of our study was to evaluate the effect of ABC on the response rate to HCV therapy...
  4. ncbi Longitudinal analysis of the 5'UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patients
    Federico Bolcic
    Instituto de Investigaciones Biomédicas en Retrovirus y Sida, Facultad de Medicina, Universidad de Buenos Aires, Argentina
    Antiviral Res 95:72-81. 2012
    ..The proteins appear to block interferon (IFN)-induced RNA-dependent protein kinase (PKR) and the 5'UTR may influence the viral lymphotropism...
  5. ncbi A clustering phenomenon among HCV-1a strains among patients coinfected with HIV from Buenos Aires, Argentina
    Federico Bolcic
    Microbiology Department, National Reference Center for AIDS Research, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
    J Med Virol 84:570-81. 2012
    ..In conclusion, these results suggest the presence of an HCV-1a monophyletic cluster with a potential HIV co-transmission by phylogenetic analyses...
  6. ncbi HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors
    Jorge F Quarleri
    Centro Nacional de Referencia para el SIDA, Dto Microbiologia, Facultad de Medicina, Universidad de Buenos Aires, CONICET, Argentina
    Acta Gastroenterol Latinoam 37:76-83. 2007
    ..Considering the increasing rate of HCV genotypes with lower response rates to treatment among HIV co-infected patients, antiretroviral therapy success might be jeopardized by HCV coinfection...
  7. ncbi Telomerase activity in peripheral blood mononuclear cells from HIV and HIV-HCV coinfected patients
    Rita Reynoso
    Centro Nacional de Referencia para el SIDA, Dto Microbiologia, Facultad de Medicina, Universidad de Buenos Aires, Argentina
    Virus Res 147:284-7. 2010
    ..The lack of an appropriate induction of this enzymatic activity after stimulus could partly account for immunosuppressive conditions observed in such patients...
  8. ncbi Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen
    Hector Perez
    Fernandes Hospital, Infectious Diseases Unit, Buenos Aires, Argentina
    Antivir Ther 13:135-9. 2008
    ..The aim of this study was to evaluate the emergence of strains resistant to NVP and lamivudine (3TC) after discontinuation of antiretroviral therapy (ART) with 3TC/zidovudine (ZDV)/NVP...
  9. ncbi ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis
    Javier Oscar Jurado
    Department of Biological Chemistry, University of Buenos Aires, School of Sciences, Buenos Aires, Argentina
    J Int AIDS Soc 15:17428. 2012
    ....
  10. ncbi Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
    M Eugenia Socías
    Hospital J A Fernandez, Cerviño 3356, Buenos Aires, Argentina
    J Int AIDS Soc 14:40. 2011
    ..Diagnosis of primary HIV infection (PHI) has important clinical and public health implications. HAART initiation at this stage remains controversial...
  11. ncbi Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study
    Lucila Cassino
    Centro Nacional de Referencia para el SIDA, Dto Microbiologia, Facultad de Medicina, Universidad de Buenos Aires, Argentina
    J Clin Virol 46:354-9. 2009
    ..The course of chronic HBV infection is modified by HIV-coexistence...
  12. ncbi Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants
    Gabriela Turk
    Centro Nacional de Referencia para el SIDA, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155 Piso 11, C1121ABG Buenos Aires, Argentina
    J Virol 82:2853-66. 2008
    ..Screening T-cell responses with multiple sets increased sensitivity. Further support for the notion of polyfunctional CD8(+) T-cell requirement to better control viral replication is also provided...